valproic acid has been researched along with metoclopramide in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 10 (41.67) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Becker, U; Doss, M; Kaffarnik, H; Peter, HJ | 1 |
| Berlin, CM | 1 |
| Abbott, FS; Axelson, JE; Doroudian, A; Gordon, JG; Riggs, KW; Rurak, DW; Tonn, GR | 1 |
| Grosberg, BM; Robbins, MS; Solomon, S; Tarshish, S | 1 |
| Gelfand, AA; Goadsby, PJ | 1 |
| Anikina, MA; Levin, OS; Shindriaeva, NN | 1 |
| Bakhshayesh, B; Hatamian, H; Hossieninezhad, M; Rezania, K; Seyed Saadat, SM | 1 |
| Bijur, PE; Esses, D; Friedman, BW; Gallagher, EJ; Garber, L; Solorzano, C; Wollowitz, A; Yoon, A | 1 |
| Factor, SA; Jankovic, J | 1 |
| Friedman, BW; Gallagher, EJ; Garber, L | 2 |
| Abu Bakar, MA; Baharuddin, KA; Norhayati, MN; Nurathirah, MN; Yazid, MB | 1 |
| Abd-ElGawad, M; Abdelhay, HM; Abdelmonem, H; Abdelwadoud, GT; Ahmed, AE; Al-Dardery, NM; Alhosini, ANM; Kamel, MA; Mohamed, SW | 1 |
7 review(s) available for valproic acid and metoclopramide
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advances in pediatric pharmacology and toxicology.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Attention Deficit Disorder with Hyperactivity; Biological Availability; Child; Child, Preschool; Female; Fetus; Humans; Infant; Infant, Newborn; Kinetics; Maternal-Fetal Exchange; Metoclopramide; Otitis Media; Otitis Media with Effusion; Pediatrics; Pharmaceutical Preparations; Pharmacology; Phenobarbital; Pregnancy; Reye Syndrome; Salamandridae; Seizures; Tourette Syndrome; Toxicology; Valproic Acid | 1983 |
New approaches for drug and kinetic analysis in the maternal-fetal unit.
Topics: Animals; Diphenhydramine; Female; Fetus; Labetalol; Metoclopramide; Pregnancy; Pregnancy, Animal; Sheep; Stereoisomerism; Valproic Acid | 1995 |
Treatment of pediatric migraine in the emergency room.
Topics: Adolescent; Age Distribution; Age of Onset; Analgesics; Antiemetics; Child; Child, Preschool; Dihydroergotamine; Disease Management; Dopamine Antagonists; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fluid Therapy; Humans; Male; Metoclopramide; Migraine Disorders; Narcotics; Neuroimaging; Prevalence; Sex Distribution; Tryptamines; Valproic Acid; Vomiting | 2012 |
Efficacy of ketorolac in the treatment of acute migraine attack: A systematic review and meta-analysis.
Topics: Caffeine; Dexamethasone; Diclofenac; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Pain; Phenothiazines; Sumatriptan; Valproic Acid | 2022 |
The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials.
Topics: Chlorpromazine; Granisetron; Headache; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Nausea; Network Meta-Analysis; Prochlorperazine; Randomized Controlled Trials as Topic; Sumatriptan; Valproic Acid | 2023 |
2 trial(s) available for valproic acid and metoclopramide
| Article | Year |
|---|---|
A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache.
Topics: Acute Disease; Adult; Analgesics; Dopamine Antagonists; Drug Therapy, Combination; Female; GABA Agents; Humans; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Male; Metoclopramide; Migraine without Aura; Pain Measurement; Prospective Studies; Serotonin 5-HT1 Receptor Agonists; Severity of Illness Index; Sumatriptan; Treatment Outcome; Valproic Acid | 2013 |
Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Antimanic Agents; Double-Blind Method; Female; Humans; Ketorolac; Male; Metoclopramide; Migraine Disorders; Prospective Studies; Time Factors; Treatment Outcome; Valproic Acid | 2014 |
15 other study(ies) available for valproic acid and metoclopramide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Drug safety in porphyria: risks of valproate and metoclopramide.
Topics: Adolescent; Epilepsy; Female; Humans; Metoclopramide; Porphyrias; Valproic Acid | 1981 |
Cluster attacks responsive to recreational cannabis and dronabinol.
Topics: Analgesics, Non-Narcotic; Cannabis; Cluster Headache; Dihydroergotamine; Diphenhydramine; Dronabinol; Drug Resistance; Drug Therapy, Combination; Fructose; Humans; Male; Melatonin; Metoclopramide; Topiramate; Treatment Outcome; Valproic Acid; Young Adult | 2009 |
[Drug-induced parkinsonism].
Topics: Anticonvulsants; Antipsychotic Agents; Calcium Channel Blockers; Cinnarizine; Diagnosis, Differential; Dopamine Antagonists; Humans; Metoclopramide; Parkinson Disease, Secondary; Valproic Acid | 2012 |
Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Antimanic Agents; Female; Humans; Ketorolac; Male; Metoclopramide; Migraine Disorders; Valproic Acid | 2014 |
Author response.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Antimanic Agents; Female; Humans; Ketorolac; Male; Metoclopramide; Migraine Disorders; Valproic Acid | 2014 |
Author response.
Topics: Authorship; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Valproic Acid | 2014 |